These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19433989)

  • 1. Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.
    Custodio AB; González-Larriba JL; Bobokova J; Calles A; Alvarez R; Cuadrado E; Manzano A; Díaz-Rubio E
    J Thorac Oncol; 2009 Jul; 4(7):891-910. PubMed ID: 19433989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant chemotherapy in NSCLC (stages I to III).
    Coleman MH; Bueno R
    Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers.
    Ikeda N; Nagase S; Ohira T
    Ann Thorac Cardiovasc Surg; 2009 Jun; 15(3):144-9. PubMed ID: 19597387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
    Wozniak AJ; Gadgeel SM
    Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer.
    Park TS; Kim HR; Koh JS; Jang SH; Hwang YI; Yoon HI; Chung JH; Kim CH; Kim SS; Kim WS; Jo J; Lee JC; Choi CM
    Lung Cancer; 2014 Nov; 86(2):262-7. PubMed ID: 25261232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise.
    Azzoli CG; Park BJ; Pao W; Zakowski M; Kris MG
    J Thorac Oncol; 2008 Jan; 3(1):84-93. PubMed ID: 18166846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).
    Toffart AC; Timsit JF; Couraud S; Merle P; Moro-Sibilot D; Perol M; Mastroianni B; Souquet PJ; Girard N; Jeannin G; Romand P; Chatellain P; Vesin A; Brambilla C; Brambilla E
    Lung Cancer; 2014 Feb; 83(2):182-8. PubMed ID: 24388706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
    Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
    Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H; Dubey S; Gandara D
    Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
    Mouillet G; Monnet E; Milleron B; Puyraveau M; Quoix E; David P; Ducoloné A; Molinier O; Zalcman G; Depierre A; Westeel V;
    J Thorac Oncol; 2012 May; 7(5):841-9. PubMed ID: 22722786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer.
    Visbal AL; Leighl NB; Feld R; Shepherd FA
    Chest; 2005 Oct; 128(4):2933-43. PubMed ID: 16236970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adjuvant chemotherapy in early-stage and locally advanced non-small cell lung cancer.
    Shapiro M
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS42-5. PubMed ID: 22614965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.
    Sève P; Reiman T; Dumontet C
    Lung Cancer; 2010 Feb; 67(2):136-43. PubMed ID: 19828208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
    Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer.
    Horn L; Sandler AB; Putnam JB; Johnson DH
    J Thorac Oncol; 2007 May; 2(5):377-83. PubMed ID: 17473651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
    Nakajima E; Katou H
    Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for non-small cell lung cancer.
    Pinder-Schenck M; Bepler G
    Minerva Chir; 2009 Dec; 64(6):611-28. PubMed ID: 20029358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coming of age of molecular tumor profiling.
    Antonoff MB; D'Cunha J
    Semin Thorac Cardiovasc Surg; 2011; 23(1):8-9. PubMed ID: 21807290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.